These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 19070440)

  • 21. Aripiprazole in the treatment of patients with alcohol dependence: a double-blind, comparison trial vs. naltrexone.
    Martinotti G; Di Nicola M; Di Giannantonio M; Janiri L
    J Psychopharmacol; 2009 Mar; 23(2):123-9. PubMed ID: 18515460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gender differences in acute tobacco withdrawal: effects on subjective, cognitive, and physiological measures.
    Leventhal AM; Waters AJ; Boyd S; Moolchan ET; Lerman C; Pickworth WB
    Exp Clin Psychopharmacol; 2007 Feb; 15(1):21-36. PubMed ID: 17295582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medications for stimulant abuse: agonist-based strategies and preclinical evaluation of the mixed-action D-sub-2 partial agonist aripiprazole (Abilify).
    Bergman J
    Exp Clin Psychopharmacol; 2008 Dec; 16(6):475-83. PubMed ID: 19086768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aripiprazole in the treatment of the psychosis prodrome: an open-label pilot study.
    Woods SW; Tully EM; Walsh BC; Hawkins KA; Callahan JL; Cohen SJ; Mathalon DH; Miller TJ; McGlashan TH
    Br J Psychiatry Suppl; 2007 Dec; 51():s96-101. PubMed ID: 18055946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The safety, tolerability, and subject-rated effects of acute intranasal cocaine administration during aripiprazole maintenance.
    Stoops WW; Lile JA; Lofwall MR; Rush CR
    Am J Drug Alcohol Abuse; 2007; 33(6):769-76. PubMed ID: 17994473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Time course of the changes in antipsychotic-induced hyperprolactinemia following the switch to aripiprazole.
    Lu ML; Shen WW; Chen CH
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1978-81. PubMed ID: 18848860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aripiprazole in children and adolescents with bipolar disorder comorbid with attention-deficit/hyperactivity disorder: a pilot randomized clinical trial.
    Tramontina S; Zeni CP; Ketzer CR; Pheula GF; Narvaez J; Rohde LA
    J Clin Psychiatry; 2009 Apr; 70(5):756-64. PubMed ID: 19389329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Young mania rating scale line item analysis in pediatric subjects with bipolar I disorder treated with aripiprazole in a short-term, double-blind, randomized study.
    Mankoski R; Zhao J; Carson WH; Mathew SJ; Forbes RA
    J Child Adolesc Psychopharmacol; 2011 Aug; 21(4):359-64. PubMed ID: 21823911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of atomoxetine on subjective and neurocognitive symptoms of nicotine abstinence.
    Ray R; Rukstalis M; Jepson C; Strasser A; Patterson F; Lynch K; Lerman C
    J Psychopharmacol; 2009 Mar; 23(2):168-76. PubMed ID: 18515446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aripiprazole effects on self-administration and pharmacodynamics of intravenous cocaine and cigarette smoking in humans.
    Lofwall MR; Nuzzo PA; Campbell C; Walsh SL
    Exp Clin Psychopharmacol; 2014 Jun; 22(3):238-47. PubMed ID: 24467369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A study investigating the acute dose-response effects of 13 mg and 17 mg Delta 9- tetrahydrocannabinol on cognitive-motor skills, subjective and autonomic measures in regular users of marijuana.
    Weinstein A; Brickner O; Lerman H; Greemland M; Bloch M; Lester H; Chisin R; Sarne Y; Mechoulam R; Bar-Hamburger R; Freedman N; Even-Sapir E
    J Psychopharmacol; 2008 Jun; 22(4):441-51. PubMed ID: 18635724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia in routine clinical care: a randomized, controlled trial.
    Barbui C; Accordini S; Nosè M; Stroup S; Purgato M; Girlanda F; Esposito E; Veronese A; Tansella M; Cipriani A;
    J Clin Psychopharmacol; 2011 Jun; 31(3):266-73. PubMed ID: 21508849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An open-label pilot study of aripiprazole for male and female veterans with chronic post-traumatic stress disorder who respond suboptimally to antidepressants.
    Youssef NA; Marx CE; Bradford DW; Zinn S; Hertzberg MA; Kilts JD; Naylor JC; Butterfield MI; Strauss JL
    Int Clin Psychopharmacol; 2012 Jul; 27(4):191-6. PubMed ID: 22475888
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Degree of dependence influences the effects of smoking on psychomotor performance and working memory capacity.
    Ashor AW
    Neurosciences (Riyadh); 2011 Oct; 16(4):353-7. PubMed ID: 21983379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study.
    Lin CH; Lin SH; Jang FL
    J Clin Psychopharmacol; 2011 Oct; 31(5):563-8. PubMed ID: 21869699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of subjective effects of aripiprazole and methamphetamine in methamphetamine-dependent volunteers.
    Newton TF; Reid MS; De La Garza R; Mahoney JJ; Abad A; Condos R; Palamar J; Halkitis PN; Mojisak J; Anderson A; Li SH; Elkashef A
    Int J Neuropsychopharmacol; 2008 Dec; 11(8):1037-45. PubMed ID: 18664303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An open randomized pilot trial on the differential effects of aripiprazole versus risperidone on anhedonia and subjective well-being.
    Liemburg E; Aleman A; Bous J; Hollander K; Knegtering H
    Pharmacopsychiatry; 2011 May; 44(3):109-13. PubMed ID: 21432752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Walking reduces cue-elicited cigarette cravings and withdrawal symptoms, and delays ad libitum smoking.
    Taylor A; Katomeri M
    Nicotine Tob Res; 2007 Nov; 9(11):1183-90. PubMed ID: 17978993
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of an electronic nicotine delivery device (e cigarette) on desire to smoke and withdrawal, user preferences and nicotine delivery: randomised cross-over trial.
    Bullen C; McRobbie H; Thornley S; Glover M; Lin R; Laugesen M
    Tob Control; 2010 Apr; 19(2):98-103. PubMed ID: 20378585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Working memory in cigarette smokers: comparison to non-smokers and effects of abstinence.
    Mendrek A; Monterosso J; Simon SL; Jarvik M; Brody A; Olmstead R; Domier CP; Cohen MS; Ernst M; London ED
    Addict Behav; 2006 May; 31(5):833-44. PubMed ID: 16009504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.